Literature DB >> 6189159

Inhibition of DNA methylation by 5-azacytidine.

P A Jones, S M Taylor, V L Wilson.   

Abstract

The nucleoside analog z5C induced marked changes in the differentiated state of mouse embryo cells and inhibited the methylation of newly synthesized DNA. Other analogs of cytidine containing modifications in the 5 position (5-aza-2'-deoxycytidine, 5-fluoro-2'-deoxycytidine, and pseudoisocytidine) also induced the formation of striated muscle cells in treated cultures and inhibited DNA methylation. Together the data suggests a causative role for the methylation of specific cytosine residues in the control of gene expression. Hemimethylated duplex DNA was extracted from cultures treated with z5C and was an efficient acceptor of methyl groups from S-adenosyl-methionine in the presence of a mouse spleen methyltransferase. The ability of this hemimethylated DNA to accept methyl groups was markedly impaired if it was pretreated with several different ultimate chemical carcinogens.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6189159     DOI: 10.1007/978-3-642-81947-6_15

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  25 in total

1.  Induced instability of two Arabidopsis constitutive pathogen-response alleles.

Authors:  Trevor L Stokes; Eric J Richards
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

2.  DNA methylation increases throughout Arabidopsis development.

Authors:  L Ruiz-García; M T Cervera; J M Martínez-Zapater
Journal:  Planta       Date:  2005-06-21       Impact factor: 4.116

Review 3.  Epigenetic regulation of protein tyrosine phosphatases: potential molecular targets for cancer therapy.

Authors:  Samson T Jacob; Tasneem Motiwala
Journal:  Cancer Gene Ther       Date:  2005-08       Impact factor: 5.987

4.  Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer.

Authors:  Gary C Hon; R David Hawkins; Otavia L Caballero; Christine Lo; Ryan Lister; Mattia Pelizzola; Armand Valsesia; Zhen Ye; Samantha Kuan; Lee E Edsall; Anamaria Aranha Camargo; Brian J Stevenson; Joseph R Ecker; Vineet Bafna; Robert L Strausberg; Andrew J Simpson; Bing Ren
Journal:  Genome Res       Date:  2011-12-07       Impact factor: 9.043

5.  5-azacytidine enhances the anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia.

Authors:  May Kung Sutherland; Changpu Yu; Martha Anderson; Weiping Zeng; Nico van Rooijen; Eric L Sievers; Iqbal S Grewal; Che-Leung Law
Journal:  MAbs       Date:  2010-07-01       Impact factor: 5.857

Review 6.  GADD45 proteins: central players in tumorigenesis.

Authors:  R E Tamura; J F de Vasconcellos; D Sarkar; T A Libermann; P B Fisher; L F Zerbini
Journal:  Curr Mol Med       Date:  2012-06       Impact factor: 2.222

Review 7.  Pharmacology of epigenetics in brain disorders.

Authors:  Pritika Narayan; Mike Dragunow
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

Review 8.  Epigenetic treatment of myelodysplastic syndromes and acute myeloid leukemias.

Authors:  Giuseppe Leone; Francesco D'Alò; Giuseppe Zardo; Maria Teresa Voso; Clara Nervi
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

9.  Synergistic effects of combined DNA methyltransferase inhibition and MBD2 depletion on breast cancer cells; MBD2 depletion blocks 5-aza-2'-deoxycytidine-triggered invasiveness.

Authors:  David Cheishvili; Flora Chik; Chen Chen Li; Bishnu Bhattacharya; Matthew Suderman; Ani Arakelian; Michael Hallett; Shafaat A Rabbani; Moshe Szyf
Journal:  Carcinogenesis       Date:  2014-09-01       Impact factor: 4.944

Review 10.  Metabolic defects provide a spark for the epigenetic switch in cancer.

Authors:  Michael J Hitchler; Frederick E Domann
Journal:  Free Radic Biol Med       Date:  2009-04-10       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.